Failure of Operative Therapy after Ovarian-Sparing Surgery for Pediatric Benign Ovarian Neoplasms: A Retrospective Review

Maria E. Knaus, Amanda J. Onwuka, Naila M. Abouelseoud, Lesley L. Breech, Katherine S. Brito, Charlene Dekonenko, S. Paige Hertweck, Helena Y. Hong, Amy E. Lawrence, Seema Menon, Diane F. Merritt, Allegra G. Schikler, Nikki Senapati, Yolanda R. Smith, Julie L. Strickland, Amber I. Truehart, Peter C. Minneci, Geri D. Hewitt*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Abstract

Study Objective: To evaluate failure of initial operative therapy (incomplete tumor removal) of ovarian-sparing surgery for pediatric benign ovarian neoplasms. Methods: A retrospective review of patients up to 21 years of age who underwent ovarian-sparing surgery for a benign ovarian neoplasm from 2010 to 2016 at 8 pediatric hospitals was conducted. Failure of initial operative therapy is defined as a radiologically suspected or pathologically confirmed ipsilateral lesion with the same pathology as the primary neoplasm within 12 weeks of the initial operation. Results: Forty patients received imaging within 12 weeks of their primary operation. Sixteen (40%) patients had a radiologically identified ovarian abnormality ipsilateral to the primary lesion, and 5 patients were suspected to have the same lesion as their primary neoplasm. Three of the 5 patients (7.5%) underwent reoperation with pathologic confirmation of the same lesion, resulting in a pathologically confirmed failure of therapy rate of 7.5%. The other 2 patients had serial imaging that subsequently demonstrated no recurrence with lesion resolution. Age, race/ethnicity, laparoscopy vs laparotomy, presence of torsion, pathology, size of lesion, and surgeon specialty were not associated with failure of therapy. Conclusion: In most patients who received imaging within 12 weeks of the primary operation for resection of a benign ovarian neoplasm, ovarian-sparing surgery was successful in complete tumor removal, with a low failure of therapy rate. Selected patients with suspected failure of therapy on initial imaging could be serially monitored to determine the need for repeat surgical intervention.

Original languageEnglish (US)
Pages (from-to)702-706
Number of pages5
JournalJournal of pediatric and adolescent gynecology
Volume35
Issue number6
DOIs
StatePublished - Dec 2022

Funding

Conception or design of the work: all authors, Acquisition, analysis, or interpretation of data for the work: AJO, NA, KSB, CD, HYH, AEL, AGS, MEK, PCM, GDH, Drafting the work or revising it critically for important intellectual content: all authors, Final approval of the version to be published: all authors, Agreement to be accountable for all aspects of the work: all authors, S. Paige Hertweck, MD, performs research with AbbVie Inc. regarding endometriosis. Yolanda R. Smith, MD, MS, and Diane F. Merritt, MD, receive royalties from UpToDate Inc. unrelated to benign ovarian neoplasms. We thank Beth McClure for assistance with data collection.

Keywords

  • Dermoid cyst
  • Mature cystic teratoma
  • Mature teratoma
  • Mucinous cystadenoma
  • Serous cystadenoma
  • Surgical outcomes

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Obstetrics and Gynecology

Cite this